U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 1,075 records

Showing results for "submit".

  1. Technical Brief 16 Disposition of Comments Report (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/advanced-care-decision-aids_disposition-comments.pdf
    July 29, 2014 - Commentators are not required to provide their names or affiliations in order to submit suggestions

  2. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pregnancy_hi_impact.pdf
    January 01, 2012 - Sequenom aiming to submit PMA application to FDA for T21 test by end of 2012. [internet]. … Available: http://www.genomeweb.com/sequencing/sequen om-aiming-submit-pma-application-fda-t21-test … c=84955&p=irol-newsArticle&ID=1560507&highlight http://www.genomeweb.com/sequencing/sequenom-aiming-submit-pma-application-fda-t21 … -test-end-2012 http://www.genomeweb.com/sequencing/sequenom-aiming-submit-pma-application-fda-t21-test-end … -2012 http://www.genomeweb.com/sequencing/sequenom-aiming-submit-pma-application-fda-t21-test-end-2012

  3. children-special-needs-transition-protocol-131003 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/children-special-needs-transition_research-protocol.pdf
    October 01, 2013 - We will submit strategies and results of indexed and grey literature searches to Key Informants to confirm … Peer reviewers who disclose potential business or professional conflicts of interest may submit comments

  4. medication-assisted-treatment-protocol-160224 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/opioid-use-disorder_research-protocol.pdf
    February 24, 2016 - Resource Center (SRC) will send email notification to relevant stakeholders about the opportunity to submit … Peer reviewers who disclose potential business or professional conflicts of interest may submit comments

  5. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1506.pdf
    November 01, 2016 - AbbVie expects to complete the pivotal trials by November 2016 and is expected to submit a new drug … complete the pivotal phase III trials by November 2016, after which the manufacturers are expected to submit

  6. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1512.pdf
    November 01, 2016 - AbbVie expects to complete pivotal trials by November 2016 and then submit a new drug application. … complete the pivotal phase III trials by November 2016, after which the manufacturers are expected to submit

  7. Evidence-based Practice Center Systematic Review Protocol (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-safety-practices_research-protocol.pdf
    November 09, 2011 - Peer reviewers who disclose potential business or professional conflicts of interest may submit comments

  8. Vitamin-D-Calcium-Protocol-130611 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/vitamin-d-calcium_research-protocol.pdf
    September 13, 2013 - Vitamin-D-Calcium-Protocol-130611 Source: www.effectivehealthcare.ahrq.gov Published online: June 10, 2013 1 Evidence-based Practice Center Systematic Review Protocol Project Title: Vitamin D and Calcium: A Systematic Review of Health Outcomes I. Background and Objectives for the Systematic R…

  9. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/dementia_hi_impact.pdf
    January 01, 2012 - DEMENTIA INCLUDING ALZHEIMER'S #04 i AHRQ Healthcare Horizon Scanning System – Potential High Impact Interventions Report Priority Area 04: Dementia (Including Alzheimer’s Disease) Potential High Impact Interventions Report Prepared for: Agency for Healthcare Research and Quality U.S. De…

  10. Disposition of Comments Report for Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma-Cell Dyscrasias (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/plasma-cell-dyscrasias-sflc-assay_disposition-comments.pdf
    August 23, 2012 - Commentators are not required to provide their names or affiliations in order to submit suggestions

  11. Disposition of Comments_Comparative Effectiveness Review NO. 243: Prehospital Airway Management (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/cer-243-prehospital-airway-management-disposition-comments.pdf
    June 14, 2021 - Commentators are not required to provide their names or affiliations in order to submit suggestions

  12. THIS IS OUR TEACHER! (ppt file)

    effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_media_wilkes.ppt
    April 01, 2006 - coverage, are less likely to publish studies that have negative results; scientists are less likely to submit

  13. Adverse Events Associated with COVID-19 Pharmaceutical Treatments (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments.pdf
    December 23, 2023 - Invited peer reviewers who disclose potential business or professional conflicts of interest may submit

  14. Atrial-Fibrillation-Addendum-140619 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-addendum-140619.pdf
    June 19, 2014 - AHRQ: CER #119, Treatment of Atrial Fibrillation Report Addendum (Submitted June 13, 2014) All searches run for the AHRQ Comparative Effectiveness Review (CER #119, Treatment of Atrial Fibrillation); found at: http://www.ncbi.nlm.nih.gov/pubmed/24887617 were updated for the Annals of Internal Medicine publicati…

  15. Disposition of Comments Report for The Effectiveness and Risks of Long-Term Opioid Treatment of Chronic Pain (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_disposition-comments.pdf
    September 29, 2014 - Commentators are not required to provide their names or affiliations in order to submit suggestions … Society NA Thank you for commissioning this report on an important topic and for the opportunity to submit … Discussion Thank you for commissioning this report on an important topic and for the opportunity to submit

  16. Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: An Update of the PTSD Repository Evidence Base (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd4-final-protocol.pdf
    October 01, 2022 - included in the prior report will be notified of their study’s inclusion in the report,10 and invited to submit … Peer reviewers who disclose potential business or professional conflicts of interest can submit comments

  17. Nonopioid Pharmacologic Treatments for Chronic Pain (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonopioid-pharm-chronic-pain-protocol.pdf
    February 01, 2019 - Evidence And Data for Systematic review (SEADS): Manufacturers of included drugs will be invited to submit … Peer reviewers who disclose potential business or professional conflicts of interest may submit comments

  18. Disposition of Comments Report for Interventions for Feeding and Nutrition in Cerebral Palsy (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cerebral-palsy-feeding_disposition-comments.pdf
    March 20, 2013 - Commentators are not required to provide their names or affiliations in order to submit suggestions

  19. Cancer-Drugs-Utilization-Cost Research (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-drugs-utilization-cost_research.pdf
    January 01, 2011 - Utilization and cost of anticancer biologic products among Medicare beneficiaries, 2006-2009 Data Points #6Anticancer Biologics From 2006 to 2009, over 800,000 Medicare fee-for-service beneficiaries continuously enrolled in Parts A and B had a claim for an anticancer biologic of interest. Bevacizumab was the m…

  20. Effectiveness of Screening and Treatment of Subclinical Hypothyroidism or Hyperthyroidism (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypothyroidism-hyperthyroidism-screening-treatment_disposition-comments.pdf
    February 01, 2012 - Commentators are not required to provide their names or affiliations in order to submit suggestions
SHARE:
Facebook Twitter Print Facebook Share

Similar Terms:

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site:

View results from all sites